Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
86.45 USD | -1.11% |
|
+1.79% | +5.46% |
Feb. 07 | Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing | MT |
Feb. 05 | Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage | MT |
Share class: Vaxcyte, Inc.
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 124,636,546 | 121,980,413 ( 97.87 %) | 0 | 97.87 % |
Major shareholders: Vaxcyte, Inc.
Name | Equities | % | Valuation |
---|---|---|---|
Fidelity Management & Research Co. LLC
12.68
%
| 15,800,667 | 12.68 % | 1 293 M $ |
Vanguard Fiduciary Trust Co.
9.179
%
| 11,440,483 | 9.179 % | 937 M $ |
Janus Henderson Investors US LLC
8.786
%
| 10,950,124 | 8.786 % | 896 M $ |
BlackRock Advisors LLC
8.272
%
| 10,309,850 | 8.272 % | 844 M $ |
RA Capital Management LP
6.972
%
| 8,689,190 | 6.972 % | 711 M $ |
Capital Research & Management Co. (Global Investors)
3.93
%
| 4,898,221 | 3.93 % | 401 M $ |
Wellington Trust Co., NA
3.622
%
| 4,513,756 | 3.622 % | 369 M $ |
T. Rowe Price International Ltd.
3.583
%
| 4,466,137 | 3.583 % | 366 M $ |
T. Rowe Price Investment Management, Inc.
3.253
%
| 4,053,828 | 3.253 % | 332 M $ |
State Street Corp.
2.733
%
| 3,405,743 | 2.733 % | 279 M $ |
░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
Breakdown by shareholder type
Institutional | 99.03% |
Other | 7.4% |
State Street Corp. | 2.73% |
Individuals | 0.91% |
Polar Capital Holdings Plc | 0.8% |
Raymond James Financial, Inc. | 0.21% |
SEI Investments Co. | 0.17% |
Schweizerische Nationalbank | 0.14% |
Manulife Financial Corp. | 0.13% |
Corebridge Financial, Inc. | 0.05% |
Based on 1000 largest holdings
Geographical origin of shareholders
United States | 99.88% |
United Kingdom | 7.93% |
Individuals | 0.91% |
Norway | 0.81% |
Denmark | 0.61% |
Canada | 0.59% |
Germany | 0.24% |
Switzerland | 0.23% |
Luxembourg | 0.1% |
Australia | 0.1% |
Ireland | 0.06% |
Sweden | 0.03% |
China | 0.03% |
Singapore | 0.02% |
South Korea | 0.01% |
Taiwan | 0.01% |
Japan | 0.01% |
Based on 1000 largest holdings
- Stock Market
- Equities
- PCVX Stock
- Company Vaxcyte, Inc.
- Share ownership